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ABSTRACT
Background: Biogenic amines (BAs) are metabolites produced by the decarboxylation of
amino acids with significant physiological functions in eukaryotic and prokaryotic cells. BAs
can be produced by bacteria in fermented foods, but little is known concerning the potential
for microbes within the human gut microbiota to produce or degrade BAs.
Objective: To isolate and identify BA-producing and BA-degrading microbes from the human
gastrointestinal tract.
Design: Fecal samples from human volunteers were screened on multiple growth media,
under multiple growth conditions. Bacterial species were identified using 16S rRNA sequen-
cing and BA production or degradation was assessed using ultra-performance liquid
chromatography.
Results: In total, 74 BA-producing or BA-degrading strains were isolated from the human gut.
These isolates belong to the genera Bifidobacterium, Clostridium, Enterococcus, Lactobacillus,
Pediococcus, Streptococcus, Enterobacter, Escherichia, Klebsiella, Morganella and Proteus. While
differences in production or degradation of specific BAs were observed at the strain level, our
results suggest that these metabolic activities are widely spread across different taxa present
within the human gut microbiota.
Conclusions: The isolation and identification of microbes from the human gut with BA-
producing and BA-degrading metabolic activity is an important first step in developing a
better understanding of how these metabolites influence health and disease.
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Introduction
The gut microbiome is composed of up to 1000
different bacterial species that encode for 100 times
more genes than those of the human genome [1].
This community of microorganisms is seen as a vir-
tual organ, responsible for important functions that
contribute to the overall health of the host [2]. An
imbalance between protective and pathogenic
microbes in the gut microbial ecosystem, termed
dysbiosis, has often been linked with various disor-
ders, such as inflammatory bowel disease, asthma,
obesity and diabetes [3,4].
The importance of the microbiota is related not
only to its taxonomic diversity, but also to the meta-
bolites that the bacteria produce and degrade. So far,
only a few microbial metabolites have been assessed
for their contribution to human health, with the
exception being short-chain fatty acids [5].
However, the human gut microbiota produces many
other metabolites that may influence the host. In this
study, we focused on identifying the human gut-
derived bacteria that produce biogenic amines
(BAs), including histamine, tyramine, cadaverine,
spermine, spermidine and putrescine. BAs are meta-
bolites produced by the decarboxylation of amino
acids (AAs), with significant physiological functions
in eukaryotic cells as they are precursors for the
synthesis of hormones, alkaloids, nucleic acids and
proteins [6]. BAs such as histamine are immune
mediators and neurotransmitters, whereas others,
such as putrescine, spermidine and spermine, are
needed for optimal cell growth and differentiation,
stabilization of the DNA negative charge, RNA tran-
scription, protein synthesis, apoptosis and regulation
of the immune response [7–12]. In bacteria, BAs are
also essential for growth and proliferation [13], but
the concentrations produced and secreted are far
higher than those of eukaryotic cells. This difference
could represent, at least in part, a defense mechanism
used by bacteria to withstand acidic stress conditions,
in addition to many other, so far unknown, cellular
and immune regulatory properties [14,15].
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The direct influence of this microbial-associated
metabolic activity on the human host, i.e. production
or degradation of BAs, has been poorly evaluated.
Spermine has been previously demonstrated to inhi-
bit pro-inflammatory cytokine secretion by lipopoly-
saccharide-stimulated peripheral blood mononuclear
cells [16] and its mucosal concentration appeared to
be reduced in patients with ulcerative colitis com-
pared to healthy controls [17]. Histamine can have
both pro-inflammatory and anti-inflammatory effects
on immunoregulatory processes, depending on which
histamine receptor is activated [18,19]. We previously
demonstrated that Lactobacillus saerimneri 30a
(which secretes histamine and cadaverine) induces
rapid weight loss and immunological effects, depen-
dent on activation of histamine receptor-2 within the
mucosa [20]. In addition, the levels of histamine-
secreting bacteria were shown to be increased in the
gut of asthma patients compared to healthy volun-
teers, and the level of one histamine-secreting
microbe positively correlated with the severity of dis-
ease [21]. In murine models, microbiota-derived
taurine, histamine and spermine were shown to influ-
ence host–microbiome interactions by co-modulating
NLRP6 inflammasome signaling, epithelial interleu-
kin-18 secretion and downstream anti-microbial pep-
tide secretion [22].
However, other than histamine, it is unknown
which BAs can be produced or degraded by bacteria
derived from the human gut. This study aims to isolate
and identify some of these microorganisms, so that a
better insight can be developed into the biological
importance of BA-producing and BA-degrading bac-
teria from the human gut in the host, as well as of the
microbiota itself. Using a rapid and simple screening
approach, numerous taxonomically different strains
were isolated and identified, and their capacities to
produce or degrade BAs were assessed.
Materials and methods
Isolation of bacterial strains
Human adult volunteers (n = 14) collected a single
fecal sample at their workplace or home residence
using a fecal collection kit (containing plastic
gloves, a cardboard seat cover, a plastic container
and a disposal bag) and the fecal sample was imme-
diately sealed in the airtight plastic container. The
sealed plastic container was placed on ice and trans-
ported to the study laboratory within 4 h. Samples
were then immediately divided into 1 g aliquots and
stored frozen until analysis at −80°C, under ambi-
ent air. Bacteria were isolated from frozen fecal
samples by adding 2 ml of phosphate-buffered sal-
ine (Life Technologies, Grand Island, NY, USA) to
1 g of feces and the obtained suspension was
vortexed until homogeneity. The solution was cen-
trifuged at 4°C at 1000 rpm for 3 min to pelletize
the fecal material. Then, 100 µl of supernatant was
plated on brain–heart infusion agar (BHI; Oxoid,
Basingstoke, UK), tryptic soy agar (TSA; Oxoid), de
Man–Rogosa–Sharpe agar (MRS; Becton Dickinson,
Sparks, MD, USA) and reinforced clostridial med-
ium agar (RCM; Oxoid). Plates were incubated at
37°C under anaerobic conditions using an anaero-
bic pouch (Oxoid). Random colonies were selected
and after three successive transfers on to the corre-
sponding solid medium, pure cultures were
obtained. Isolates were stocked in 40% glycerol
(Sigma-Aldrich, St. Louis, MO, USA) at −80°C.
For clarity, Gram-positive and Gram-negative bac-
teria are separated in all the tables.
16S rRNA identification of the isolates
Molecular identification of the isolates was performed
by sequencing the 16S ribosomal RNA (rRNA)
regions without a prior DNA extraction step, by
colony polymerase chain reaction (PCR). A single
colony was isolated and DNA amplified via PCR
using primers 27F and 1492R and GoTaq Green
Master Mix polymerase (Promega Corporation,
Madison, WI, USA) under the following conditions:
95°C for 4 min; 95°C for 40 s, 54°C for 45 s and 72°C
for 1 min (32 cycles); and 72°C for 5 min. The 16S
rRNA genes were sequenced by GATC Biotech
(Constance, Germany) and subsequently compared
with all GenBank entries by a BLASTN search.
Quantification of BAs
To assess BA production by the isolated bacteria, all
strains were grown in liquid medium (BHI, TSB,
MRS and RCM) containing pyridoxal-5-phosphate
at 37°C and under anaerobic conditions in 14 ml
round-bottomed polystyrene tubes. In addition, med-
ium was supplemented with an AA cocktail (0.1%
final concentration each of histidine, lysine, arginine,
ornithine and tyrosine) or a BA cocktail (0.03% final
concentration each of histamine, cadaverine, sper-
mine, spermidine, putrescine and tyramine).
Bacterial supernatants were collected after 48 h cul-
ture by centrifugation at 14,000 rpm for 10 min.
Samples were stored at −20°C until derivatization.
Standard chemicals for spermidine trihydrochloride,
histamine dihydrochloride, putrescine dihydrochloride
(Acros Organics, Morris, NJ, USA), cadaverine dihy-
drochloride, spermine tetrahydrochloride and tyramine
hydrochloride (Sigma-Aldrich, St. Louis, MO, USA)
were of analytical grade. Standard stock solutions were
prepared at 1000 mg/l in distilled water, and were
further diluted to generate standard curves.
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In the next step, 475 μl of bacterial supernatant or
standard solution was mixed with 25 μl of 5 g/l 1,7-
diaminoheptane (Internal standard; Sigma-Aldrich,
St. Louis, MO, USA), 100 µl of 2 M NaOH, 150 µl
of saturated sodium bicarbonate solution and 1 ml of
dansyl chloride (Sigma-Aldrich) solution (10 mg/ml
in acetone), and then incubated at 40°C, 200 rpm, for
45 min. Residual dansyl chloride was removed by
adding 50 µl of 25% ammonium hydroxide (Merck,
Darmstadt, Germany). After 30 min at 25°C, the
volume was adjusted to 2.5 ml with acetonitrile
(Biosolve Chimie, Dieuze, France) and centrifuged
at 3500 rpm for 5 min, and supernatants were filtered
(0.22 µm) before ultra-performance liquid chromato-
graphy (UPLC) analysis. Duplicate samples were ana-
lyzed in parallel.
Separation was carried out by UPLC on an
ACQUITY UPLC H-Class Bio System (Waters
Corp., Milford, MA, USA) equipped with a quatern-
ary solvent manager, sample manager with flow-
through needle, column manager and diode array
detector. Data processing was performed using
MassLynx v. 4.1 (Waters Corp.). Based on their dif-
ferent hydrophobicities, the dansylated BAs were
separated on an ACQUITY UPLC BEHC18 column
(1.7 µm particle size, 2.1 mm x 50 mm; Waters Corp.)
and the samples were eluted with a gradient elution
of (A) acetonitrile (100%), (B) acetonitrile (50%) as
follows: 0–0.72 min, A 40%, B 60%; 0.72–1.07 min, A
40–80%, B 60–20%; 1.07–1.42 min, A 80–90%, B
20–10%; 1.42–2.11 min, A 90–95%, B 10–5%; 2.11–
2.46 min, A 95–40%, B 5–60%, 2.46–4.20 min, A 40%,
B 60%. The flow rate was kept at 0.6 ml/min, column
temperature at 25°C and injection 1 µl and the detec-
tion wavelength was 217 nm.
Results
Isolation of gut bacterial strains
Extensive literature reviews suggested that the BA-
producing bacteria isolated from food were mostly
facultative anaerobes and generally belong to the
phyla Firmicutes and Proteobacteria. Therefore, we
decided to search for new isolates using the media
MRS, RCM, TSB and BHI, under anaerobic condi-
tions generated by anaerobic pouches.
From the 14 volunteers [seven male and seven
female, all Caucasian, with a median age of 39 years
(range 22–60 years) and median body mass index of
23.2 kg/m2 (range 20.2–24.902 kg/m2)], a total of 74
presumptive BA-producing strains was isolated. The
16S rRNA gene sequences of the isolates were deter-
mined and compared with those deposited in
Genbank. The results showed that the strains were
closely related (similarity of >99% for all strains) to
the genera Bifidobacterium, Clostridium, Enterococcus,
Lactobacillus, Pediococcus, Streptococcus, Enterobacter,
Escherichia, Klebsiella, Morganella and Proteus. In
total, 54 isolates were Gram positive (Table 1) and 20
isolates were Gram negative (Table 2).
Bacterial production of BAs in the presence of
AAs
To assess the production of BAs, strains were grown
for 48 h in the presence of an AA cocktail (containing
histidine, lysine, arginine, ornithine and tyrosine) and
supernatants were subsequently assessed by UPLC.
Table 1. Gram-positive isolates, medium used for their isola-
tion and 16S rRNA Genbank accession number.
Strain Medium
Genbank accession
no.
Bifidobacterium adolescentis A.1 BHI KX674032
Bifidobacterium longum A.2 RCM KX674040
A.3 RCM KX673988
Bifidobacterium
pseudocatenulatum
A.4 RCM KX674010
A.5 RCM KX673984
A.6 BHI KX674008
A.7 RCM KX673991
A.8 RCM KX673986
Clostridium perfringens B.1 BHI KX674025
B.2 BHI KX674031
B.3 BHI KX674026
Enterococcus avium C.1 TSB KX673997
C.2 BHI KX674028
Enterococcus faecalis C.3 TSB KX674015
C.4 TSB KX674016
C.5 TSB KX674019
C.6 TSB KX674022
C.7 TSB KX674023
C.8 TSB KX674046
C.9 TSB KX674051
C.10 TSB KX674048
C.11 TSB KX674045
C.12 TSB KX674012
C.13 TSB KX674013
C.14 TSB KX674014
Enterococcus faecium C.15 MRS KX674033
Enterococcus gallinarum C.16 BHI KX674030
Enterococcus sp. C.17 RCM KX673985
Lactobacillus crispatus D.1 MRS KX674034
D.2 MRS KX674035
Lactobacillus fermentum D.3 MRS KX674011
D.4 MRS KX674003
D.5 MRS KX674004
D.6 MRS KX674002
D.7 RCM KX674007
Lactobacillus gasseri D.8 MRS KX673989
D.9 MRS KX673998
D.10 MRS KX673995
Lactobacillus salivarius D.11 MRS KX674005
D.12 MRS KX673996
D.13 MRS KX674006
D.14 MRS KX673990
D.15 MRS KX673994
D.16 RCM KX674009
D.17 RCM KX673980
D.18 RCM KX673983
D.19 RCM KX673981
D.20 MRS KX673993
D.21 MRS KX674037
Lactobacillus vaginalis D.22 MRS KU612267
Pediococcus pentosaceus E.1 MRS KX674036
E.2 MRS KX674038
Streptococcus salivarius F.1 MRS KX674039
Streptococcus vestibularis F.2 MRS KX673987
BHI, brain–heart infusion; RCM, reinforced clostridial medium; TSB, tryptic
soy broth; MRS, de Man–Rogosa–Sharpe.
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All isolates produced at least one BA; however, sig-
nificant differences between species were observed. A
representative UPLC plot is shown in supplementary
Figure S1.
In general, Gram-negative bacteria seemed to gen-
erate more BAs than Gram-positive bacteria
(Figure 1). Putrescine and cadaverine were the main
BAs produced by the majority of Gram-negative bac-
teria, but were not usually secreted by Gram-positive
bacteria (Figure 1). The only exceptions were the two
strains of Enterococcus faecalis (C.10 and C.11) that
were capable of producing cadaverine. Histamine
secretion was rarely observed, with only one Gram-
positive strain (Lactobacillus vaginalis, D.22) and one
Gram-negative strain (Morganella morganii, J.1)
showing high levels of histamine secretion (Figure 1).
Tyramine was produced by the majority of
Enterococcus strains, but in some species specificity
was observed since tyramine was not produced by the
E. avium or E. gallinarum isolates (Figure 1).
Tyramine was produced by only four Gram-negative
isolates: two Escherichia coli strains (H.1 and H.10),
one Klebsiella pneumoniae strain (I.1) and Morganella
morganii (J.1).
Spermidine was produced by all strains from the
genera Bifidobacterium, by two of the three
Clostridium isolates (B.1 and B.2), but by only two
of the 17 Enterococcus strains (C.1 and C.17).
Lactobacillus crispatus and Lactobacillus gasseri
strains were not able to produce spermidine, but
Lactobacillus fermentum, Lactobacillus salivarius
(except D.21) and Lactobacillus vaginalis were cap-
able of producing spermidine (Figure 1). The
Pediococcus and Streptococcus isolates also secreted
spermidine (Figure 1). For Gram-negative bacteria,
only two E. coli strains (H.7 and H.8), one K. pneu-
moniae strain (I.2) and Proteus mirabilis (K.1) were
capable of secreting spermidine under these culture
conditions (Figure 1).
Spermine was secreted by all Gram-positive
strains, except for five Enterococcus isolates (C.6,
C.7, C.8, C.9 and C.14). Similarly, spermine was
secreted by all Gram-negative isolates, except for K.
pneumoniae I.1 (Figure 1).
Tabulated data for Gram-positive and Gram-nega-
tive bacteria can be observed in supplementary Tables
S1 and S2, respectively.
Bacterial production and degradation of BAs in
the presence of BAs
In vivo, bacteria are exposed to multiple substrates
and may not produce BAs in the sole presence of
AAs. Thus, we determined whether these isolated
strains could produce or degrade BAs in the presence
of other BAs (putrescine, cadaverine, histamine, tyr-
amine, spermidine and spermine). Strains were
grown for 48 h in the presence of the BA cocktail
and supernatants were quantified by UPLC.
Putrescine levels were decreased following incuba-
tion with the majority of Gram-positive strains
(Figure 2), other than the Enterococcus strains C.1,
C.10 and C.11. Gram-negative strains increased or
decreased putrescine levels independently of species,
with some strains increasing putrescine levels and
other strains decreasing levels.
Similarly to changes in putrescine levels, the
majority of Gram-positive strains utilized or
degraded cadaverine that led to reduced cadaverine
levels (Figure 2). Two of the three Enterococcus iso-
lates that had increased putrescine levels also
increased cadaverine levels (C.10 and C.11). Co-incu-
bation of BAs with Gram-negative microbes resulted
in increased levels of cadaverine for the majority of
isolates tested (Figure 2). The only exceptions were
Enterobacter cloacae (G.1), M. morganii (J.1) and P.
mirabilis (K.1).
In contrast, the vast majority of both Gram-posi-
tive and Gram-negative isolates increased the level
of histamine when co-cultured in the presence of the
BA cocktail (Figure 2). However, a small number of
strains was able to degrade and/or utilize histamine.
All of the Gram-positive Clostridium perfringens iso-
lates (B.1, B.2 and B.3) reduced histamine levels,
while the Gram-negative strains E. coli (H.1, H.9
and H.14) and K. pneumoniae (I.2) also reduced
histamine levels. Of note, E. coli H.9 completely
removed all histamine that was added to the culture.
The UPLC plot for E. coli H.9 illustrating the
removal of histamine can be observed in supplemen-
tary Figure S2.
Tyramine levels were reduced by all Gram-positive
isolates, except for Enterococcus species (Figure 2). As
described above, tyramine was not produced by the E.
Table 2. Gram-negative isolates, medium used for their iso-
lation and 16S rRNA Genbank accession number.
Strain Medium Genbank accession no.
Enterobacter cloacae G.1 TSB KX674047
Escherichia coli H.1 TSB KX673982
H.2 TSB KX674041
H.3 TSB KX674042
H.4 TSB KX673999
H.5 TSB KX674000
H.6 TSB KX674001
H.7 TSB KX674043
H.8 TSB KX674044
H.9 TSB KX674017
H.10 TSB KX674018
H.11 TSB KX674020
H.12 TSB KX674021
H.13 BHI KX674027
H.14 BHI KX674029
Escherichia fergusonii H.15 TSB KX673992
Klebsiella pneumoniae I.1 TSB KX674052
I.2 TSB KX674024
Morganella morganii J.1 TSB KU6122676
Proteus mirabilis K.1 TSB KX674049
TSB, tryptic soy broth; BHI, brain–heart infusion.
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avium or E. gallinarum isolates in the presence of AAs
and also was not produced in the presence of BAs
(Figure 2). Similarly to the Gram-positive isolates,
tyramine levels were reduced by the majority of
Gram-negative bacteria, except for E. coli (H.1 and
H.10), M. morganii (J.1) and K. pneumoniae (I.2).
Spermidine levels were increased following co-
incubation with BAs for the majority of both Gram-
positive and Gram-negative bacteria (Figure 2).
However, all the Gram-positive C. perfringens isolates
(B.1, B.2 and B.3) reduced spermidine levels, while
the Gram-negative strains E. coli (H.6, H.9 and H.14)
also reduced spermidine levels. This metabolic activ-
ity is similar to that described above for the reduction
of histamine levels.
Finally, spermine levels were increased following
co-incubation of BAs with all microbes tested, with
the exception of the Gram-negative strain E. coli
Figure 1. Gut-derived bacteria produce biogenic amines from amino acids (AAs). Production of putrescine, cadaverine,
histamine, tyramine, spermidine and spermine (mg/l) in the presence of AAs by isolated strains is illustrated. Results are
expressed as the mean of two independent experiments. In total, 54 isolates are Gram positive (Table 1) and 20 isolates are
Gram negative (Table 2).
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(H.9), which seems to have the unusual ability to
degrade and/or utilize the majority of BAs tested.
Tabulated data for differences in BA concentra-
tions compared to the uninoculated control media
(supplemented only with the BA cocktail) are shown
in supplementary Tables S3 and S4 for Gram-positive
and Gram-negative strains, respectively.
Discussion
The in vivo influence of microbial-derived BAs on the
host is still poorly understood. Nonetheless, with the
high level of BA monitoring in food products [23], it
is equally important to determine the identity of
bacterial strains and influence of the production of
BAs by the resident microbiota in the human gut,
Figure 2. Gut-derived bacterial biogenic amine (BA) metabolism is altered in the presence of BAs. Production and degradation
of putrescine, cadaverine, histamine, tyramine, spermidine and spermine (mg/l) in the presence of BAs by isolated strains is
illustrated. A positive number represents an increase, while a negative number represents a decrease in BA concentration.
Results are expressed as the mean of two independent experiments. In total, 54 isolates are Gram positive (Table 1) and 20
isolates are Gram negative (Table 2).
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independently from consumption of these BAs. Our
data suggest that many different microbial species can
produce, utilize or degrade BAs.
Of the 74 gut isolates we tested, the production or
degradation of BAs appeared to be a common, rather
than a rare, microbial metabolic activity, with some
important differences between species and strains.
For example, some strains could produce histamine
and/or tyramine at levels above the maximum limit
tolerated in fish products (histamine 200 mg/kg; tyr-
amine 100 mg/kg), as required by the US Food and
Drug Administration (FDA) and the World Health
Organization (WHO) [24,25]. Tyramine secretion
was observed for most of the Enterococcus species,
as reported before for Enterococcus strains isolated
from meat, cheese, fish and wine [26]. The secretion
of tyramine from Gram-negative bacteria could not
be associated with a specific species; rather, it was a
strain-specific trait (observed for two E. coli strains,
one K. pneumoniae strain and M. morganii).
Potentially, horizontal gene transfer could represent
a putative mechanism for dissemination of tyramine-
related metabolic genes across different taxa [27,28].
Putrescine and cadaverine were secreted primarily
by Gram-negative bacteria, as previously reported by
other research groups [29,30]. The production of cada-
verine by two strains of E. faecalis is, however, more
surprising, since previous reports did not detect cada-
verine production by this species [31]. Although cada-
verine is only toxic at high doses, it was previously
shown to potentiate histamine toxicity in rats and
guinea pigs [32]. More studies are needed to determine
the synergic effects between BAs, but an in vivo imbal-
ance of BAs could result in damage to the host.
An increased level of histamine in the gastrointest-
inal tract is associated with a range of mucosal
inflammatory disorders [20,22]. In this study, ele-
vated histamine production was observed in the pre-
sence of AAs only with strains M. morganii and L.
vaginalis, as previously reported by others [33,34].
More surprisingly, an increase in histamine concen-
tration was observed for almost all strains when
incubated with BAs.
Spermidine and spermine are usually formed
from putrescine, which probably explains the signif-
icant increase in the secretion of these two BAs when
the bacterial isolates were incubated with the BA
cocktail, compared to the AAs cocktail. However,
many of the Gram-positive strains were able to
secrete both spermidine and spermine in the pre-
sence of AA alone, even though no putrescine was
secreted by these microbes. This suggests that all the
putrescine formed by these strains was immediately
converted, or that spermidine and spermine were
formed from an alternative substrate. Spermidine
and spermine are molecules with known regulatory
functions in prokaryotic and eukaryotic cells [13],
and their concentration appeared to be normally
tightly controlled in bacteria [35]. That drastic dif-
ference in histamine, spermidine and spermine con-
centrations may represent a system of regulation in
the presence of one or several BAs. Very few data to
date have suggested that BAs possess self-regulatory
activities; however, it was demonstrated that the
protein AtoC/Az (an ornithine decarboxylase inhibi-
tor) from E. coli was regulated at a transcriptional
level in the presence of BAs [36].
The in vivo impact of this drastic change in BAs
levels is difficult to interpret at this stage, but taken
together, these data emphasize the importance of
further exploring the regulatory mechanisms behind
the production of BAs by bacteria, as well as the
synergistic effects of BAs from a toxicological point
of view. One obvious limitation of our current study
is that we did not examine these isolates for their
ability to secrete catecholamines and serotonin, which
are important neurotransmitters. However, recent
studies by others have clearly shown the presence
and importance of these metabolites from gut-asso-
ciated microbes, including the bidirectional character
of microbiota–host interactivity via neuromediators
including BAs [37,38].
A small number of bacteria isolated from food
has been described as BA degraders, including
Micrococcus varians [39], Natrinema gari [40],
Brevibacterium linen [41], Vergibacillus sp. SK33
[42], Lactobacillus sakei, Lactobacillus curvatus
[43] and Staphylococcus xylosus [44]. To our
knowledge, there is no information available about
the in vivo presence of BA-degrading bacteria
within the gut of humans. In this study, we
observed that all isolated strains of C. perfringens
had the highest overall BA-degrading capacities,
with decreased concentrations of putrescine, cada-
verine, histamine, tryramine and spermidine, and
increased concentration of spermine. Previous
reports have shown that C. perfringens was a BA
producer rather than a BA degrader, with secretion
of histamine [45], cadaverine and putrescine being
described [46]. The strains isolated in this study
did not display this trend even when grown in
the presence of AAs. One could speculate that the
BA degraders might be used as potential beneficial
strains to counteract an unbalanced gut microbiota
consisting of harmful BA producers. Of note, the L.
fermentum and B. pseudocatenulatum strains dis-
played good overall degradative capabilities and
are known as potential probiotic species. On the
other hand, increased exposure to BA degradation
products may be a contributory factor to the devel-
opment of various serious chronic and acute dis-
eases [47]. More studies are therefore required to
determine the impact and role of BA degraders in
host–microbiota interactions.
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Finally, one BA-degrading bacterium that caught our
attention was E. coli H.9. Besides being able to utilize
putrescine, tyramine and spermidine, E. coli H.9 is the
only isolate that was able to remove 100% of the hista-
mine present in the medium. Further physiological and
genomic analyses are currently underway with this
strain to determine the molecular mechanisms under-
pinning this activity, and further studies will examine
the functional ability of this microbe to reduce the
severity of allergic responses mediated by histamine.
In this study, we report for the first time the diversity
of human gut bacteria producing and/or degrading
BAs. These isolates were taxonomically heterogeneous
and produced dissimilar levels of BAs depending on the
strains and the culture conditions used. Additional stu-
dies are needed to determine how these BAs interact
and are regulated in vivo, which, in turn, would help us
to understand the complex mechanisms of BA toxicity
occurring between host and microbiome. Our data also
emphasize that studies on host–microbiota interaction
relying solely on 16S rRNA sequencing may lack essen-
tial metabolomic information needed to fully under-
stand the metabolic and immunological impact of an
altered gut microbiota composition.
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